Effect of histone deacetylase inhibitors on cell apoptosis and expression of the tumor suppressor genes RUNX3 and ARHI in ovarian tumors

Molecular Medicine Reports

Volumn 7, Issue 5, 2013, Pages 1705-1709

  Zhang, Lan ^a,b   Liu, Peishu ^a   Li, Hua ^b   Xue, Fuying ^b  

^a SHANDONG UNIVERSITY   (China)

^b Tai'an Central Hospital   (China)

Author keywords

Aplasia Ras homolog member I; Cell line; Ovarian cancer; Polymerase chain reaction; Runt box 3; Trichostatin A

Indexed keywords

APLASIA RAS HOMOLOG MEMBER I PROTEIN; CISPLATIN; MESSENGER RNA; TRANSCRIPTION FACTOR RUNX3; TRICHOSTATIN A; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; FEMALE; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY TUMOR; PREDICTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TUMOR SUPPRESSOR GENE; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CELL PROLIFERATION; CISPLATIN; CORE BINDING FACTOR ALPHA 3 SUBUNIT; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; MIDDLE AGED; OVARIAN NEOPLASMS; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 84875980902     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1371     Document Type: Article

References (18)

1. Rosen DG, Wang L, Jain AN, et al: Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival. Clin Cancer Res 10: 6559-6566, 2004.
2. Weber F, Aldred MA, Morrison CD, et al: Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis. J Clin Endocrinol Metab 90: 1149-1155, 2005.
3. Bao JJ, Le XF, Wang RY, et al: Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway. Cancer Res 62: 7264-7272, 2002.
4. Yang N, Zhang L, Zhang Y and Kazazian HH Jr: An important role for RUNX3 in human L1 transcription and retrotransposition. Nucleic Acids Res 31: 4929-4940, 2003.
5. Fukamachi H: Runx3 controls growth and differentiation of gastric epithelial cells in mammals. Dev Growth Differ 48: 1-13, 2006.
6. Hisatomi H, Nagao K, Wakita K and Kohno N: ARHI/NOEY2 inactivation may be important in breast tumor pathogenesis. Oncology 62: 136-140, 2002.
7. Luo RZ, Peng H, Xu F, et al: Genomic structure and promoter characterization of an imprinted tumor suppressor gene ARHI. Biochim Biophys Acta 1519: 216-222, 2001.
8. Derrane M: Gene imprinting: making an impression on cancer research. J Natl Cancer Inst 91: 16-18, 1999.
9. Osaki M, Moriyama M, Adachi K, et al: Expression of RUNX3 protein in human gastric mucosa, intestinal metaplasia and carcinoma. Eur J Clin Invest 34: 605-612, 2004.
10. Holzer AK, Katano K, Klomp LW and Howell SB: Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells. Clin Cancer Res 10: 6744-6749, 2004.
11. Steffensen KD, Waldstrøm M, Grove A, et al: Improved classification of epithelial ovarian cancer: results of 3 danish cohorts. Int J Gynecol Cancer. 21: 1592-1600, 2011.
12. Takai N, Kawamata N, Gui D, Said JW, Miyakawa I and Koeffler HP: Human ovarian carcinoma cells: histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis. Cancer 101: 2760-2770, 2004.
13. Fujii S, Luo RZ, Yuan J, et al: Reactivation of the silenced and imprinted alleles of ARHI is associated with increased histone H3 acetylation and decreased histone H3 lysine 9 methylation. Hum Mol Genet 12: 1791-1800, 2003.
14. Li L, Shi H, Yiannoutsos C, Huang TH and Nephew KP: Epigenetic hypothesis tests for methylation and acetylation in a triple microarray system. J Comput Biol 12: 370-390, 2005.
15. Danaher RJ, Jacob RJ, Steiner MR, Allen WR, Hill JM and Miller CS: Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript-independent manner in neuronal cells. J Neurovirol 11: 306-317, 2005.
16. Woolf E, Xiao C, Fainaru O, et al: Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis. Proc Natl Acad Sci USA 100: 7731-7736, 2003.
17. Bangsow C, Rubins N, Glusman G, et al: The RUNX3 gene - sequence, structure and regulated expression. Gene 279: 221-232, 2001.
18. Waki T, Tamura G, Sato M, Terashima M, Nishizuka S and Motoyama T: Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia. Cancer Sci 94: 360-364, 2003.